Basel Agenda 2016 during the Life Science Week 2016

+ConCepThink Tank & Strategy Consultant
2nd International Outcomes Symposium
The Basel Agenda 2016
Aspiration for Growth: A Roadmap
Basel, September 20th 2016

BA_2016_20160920_v1 2
Welcome to the Basel Agenda 2016
“Aspirational healthcare outcomes” Symposium
Two Panel discussions:
Focus
Global disruption for Value Outcomes
Quality Health – Prevention to Post care
Business Models – Where/ How to win?
Interaction
Audience Questions
Sli.do – Instant audience input to polls and
input on key questions for the future
“The Basel Agenda 2030 Report:
An aspirational Roadmap on Healthcare Transformation”
To be published in December 2016
Two Sessions:
Today’s Winners
What can we learn from innovative
healthcare value chains model
Beyond reimbursement
How disruptive strategies will impact
tomorrow’s healthcare delivery

Welcome our speakers
3BA_2016_20160920_v1
Manual Heuer
COO, dacadoo.com
Reto Schegg
CEO, Healthbank
Patrick Kersten
CEO, Doctena
Philipp Lichtenberg
Director Sales, Visionarity
Beatus Hofrichter (moderator)
Managing Director, ConCeplus
Aleksandar Ruzicic (moderator)
Partner, Executive Insight/ INSEAD Alumni Association Switzerland
The speakers
(in order of
appearance)

Three step approach for Session I
4BA_2016_20160920_v1
Step
Duration
1. Opening
presentation
2. Panel
discussion
3. Q&A with the
audience
<60 minutes 45+ minutes <30 minutes
 Welcome and food
for thought
 Speakers intro-
ductions
 Opening statements
(up to 15 minutes)
 How will digital/ ICT
IMPACT healthcare?
 Which digital/ ICT
TRENDS will impact
healthcare most?
 Where will digital/ ICT
healthcare LEADERS
come from?
 Introduce yourself
with name/affiliation
 Make your
contributions
 Target a question to
panel member(s)

The experts combine a variety of perspectives
together
5BA_2016_20160920_v1
DR. JÜRGEN RATHS
Variety of perspectives…
 …across many ICT disciplines and sectors (mainly private perspective)
 …as managers/leaders and innovators/ visionars
 …on quality health, ICT, and potentials customer behavior impact
Manuel Heuer
 COO Dacadoo
 Senior roles at
innovation leaders in
Medtech (St. Jude -
CH, Boston Scientific)
Reto Schegg
 CEO Healthbank
 Leading roles in ICT
companies (incl.
Swisscom) and Health
insurance
Patrick Kersten
 CEO Doctena
 20 years of ICT start-
up experience
 Creative
entrepreneurs
Philipp Lichtenberg
 Director Sales
Visionarity
 Focus on consumer
marketing, healthcare
sustainability, speech
and facial recognition

TODAY‘S WINNERS
What can we learn from innovative healthcare value chains model
A visionary forum for Healthcare & Life Science
stakeholders & corporate decision makers

BA_2016_20160920_v1 7
Basel Agenda 2016 – Session I
Today‘s Winners
Influencing personal health & wellbeing via
wearables & health promoting platforms
Manuel Heuer
COO
dacadoo

BA_2016_20160920_v1 8
Today‘s Winners
When consumer health and health care delivery
is aligned!
Reto Schegg
CEO
Healthbank.org

BA_2016_20160920_v1 9
Today‘s Winners
How booking platforms will influence patient
journeys
Patrick Kerster
CEO
Doctena

BA_2016_20160920_v1 10
Today‘s Winners
New adherence potentials in joint B2C models
Phil Lichtenberg
Director Sales
Visionarity

11
Today‘s Winners
Today’s Winners - A very brief outlook
Beatus Hofrichter
Managing Director
Conceplus

BA_2016_20160920_v1 12
A „Quality Health“ driven offering focus will drive
future growth
Source: B. Hofrichter, A. Ruzicic, Dr. P. Dümmler “GMTI 2013 Report – Accelerating Transformation for Success”

BA_2016_20160920_v1 13
Tomorrows demand calls for new offering
structure
Connectivity
Source : ConCep+; McKinsey & Co, April 2015
Mobil
Devices
Integration
Internet of
Things
Integration
Traditional
MedTech
Offering
Product ServicesData Apps
Remark:
This model illustrates the dynamics and changes facing Medtech offering structures as a result emerging IoT technologies. It is a model developed
by CC+ market insights, based on secondary research and expert discussions. This graph solely provides an indicative high-level viewpoint. We
recommend a thorough product strategy review within and across all portfolio offerings to analyze any potential future strategic gaps.
0% 25% 50% 75% 100%
Todays
Offering
Future
Offering
© 2016. ConCep+
Mobil
Devices
Integration
IoT
Integration
Traditional
Offering

Holistic lock-up strategies are unfolding
(and in Pharma/Biotech)
Within firms span of control External parties
14
… appliying global ICT process data “game”
TelehealthHome nurse PharmaciesGP
Private
specialists/
Secondary
care
ICT
Pharma/ Biotech
Medtech
Regulations
Clinical Data Mgmt.
Local event prediction
on
Cold, Flu, and Allergies
Bio-electronics
BA_2016_20160920_v1

Holistic lock-up strategies are unfolding, …..
(in Medtech)
Within firms span of control External parties
15
Mobil OPs KOL teams Home/ Post Care
Coordinate
DRG
holistically
MedTech Manufacturer
GP
Top KOL team
Logistics
OP Planning
Post OP Care
DRG adaptation
Gov. Adm.
QA/Monitoring
Suppliers
Fully integrated
Disease Management
Strategy
Fully integrated
Disease Management
Offerings
Fully integrated
Disease Management
Processes & IT landscape
Sys
Library
Performance /
Outcome/ QA
Solutions
Vendor Mgmt &
Inventory
Solutions
Vendor
A
Vendor
B
Vendor
D
Vendor
X
Vendor
E
Vendor
C
QA
evaluation
… applying global holistic process interface “game”
BA_2016_20160920_v1

BA_2016_20160920_v1 16
Today‘s Winners
Today’s Winners – Panel discussion

BSLW WLAN
17BA_2016_20160920_v1

You can participate today in two different ways
18BA_2016_20160920_v1
1. Open a browser on your smart device
2. Go to the website www.slido.com
3. Type-in the event code #3322
Post new questions/
endorse posted ones
(to ask the panel)
Answer a poll and
see the real-time
results on the screen

Now, it is your turn to get involved and ask
questions!
19BA_2016_20160920_v1
Please
 Introduce yourself with name/affiliation
 Make your contributions
 Target a question to panel member(s)
Manuel Heuer Reto Schegg Patrick Kersten Philipp Lichtenberg

BEYOND REIMBURSEMENT
How disruptive strategy impacts healthcare delivery tomorrow
A visionary forum for Healthcare & Life Science
stakeholders & corporate decision makers
Basel
September 20, 2016
Convergence of digital & genomic revolutions
with health, healthcare, living, and society
From 2009… … until 20XY?

Welcome our speakers
21BA_2016_20160920_v1
Herb Riband
Vice President Value, Access & Policy, Amgen (Europe)
Zayna Khayat
Senior Advisor, Health System Innovation and Director, MaRS EXCIT
Ben van Ommen
TNO – The Netherlands Organisation for Applied Scientific Research
Aleksandar Ruzicic (moderator)
Partner, Executive Insight/ INSEAD Alumni Association Switzerland
Beatus Hofrichter (moderator)
Managing Director, ConCeplus
The speakers
(in order of
appearance)

Three step approach for Session II
22BA_2016_20160920_v1
Step
Duration
1. Opening
presentation
2. Panel
discussion
3. Q&A with the
audience
<60 minutes 45+ minutes <30 minutes
 Welcome and food for
thought
 Speakers intro-
ductions
 Opening statements
(up to 15 minutes)
 What is VALUE in
healthcare?
 Which factors drive
healthcare
DISRUPTION?
 Who are the future
healthcare
LEADERS?
 Introduce yourself
with name/affiliation
 Make your
contributions
 Target a question to
panel member(s)

The experts combine a variety of perspectives
together
23BA_2016_20160920_v1
DR. JÜRGEN RATHS
Variety of perspectives…
 …across many healthcare sectors, including public/ private perspectives
 …as managers/leaders and innovators/ researchers
 …on medicine, science and healthcare systems/ Eucomed
Herb Riband
 Biotech (Amgen) and medtech
(Medtronic) senior executive
 Leading roles in associations,
(EBE/EFPIA, Eucomed, etc.)
Zayna Khayat
 Health system innovation from
start-up/ Ontario perspective
 Strategy consulting in global
health and life sciences sector
Ben van Ommen
 Applied systems biology
to metabolic health
 Integrated solutions for
personal health

BA_2016_20160920_v1 24
Basel Agenda 2016 – Session II
Beyond Reimbursement
Bringing greater value to EU healthcare systems:
Maximizing outcomes & optimizing costs
Herb Riband
Vice President Value, Access & Policy
Amgen (Europe)

25
Canada: a destiny for healthcare innovators
Zayna Khayat
Senior Advisor, Health System Innovation and Director
MaRS EXCIT

26
How can we make type 2 diabetes 13 times
cheaper and cure the patients in doing so?
Ben van Ommen
Principle Investigor
TNO - The Netherlands Organisation for applied scientific
research

27
Beyond Reimbursement – Food for thought
Aleksandar Ruzicic
Partner
Executive Insight

What is VALUE in healthcare?
28BA_2016_20160920_v1
Value-based competition in healthcare principles
1. Increase value for patients
2. Demonstrate real-world results
3. Focus on medical conditions over full cycle of care
4. Build experience, scale & learning for a medical condition
5. Compete beyond local geographies, ideally globally
6. Create data & transparency on all value aspects
Source: Porter/ Teisberg “Value-based competition in healthcare”, “Redefining Health Care”
Outcome
Total costs
How can one show
improvement over
Standard-of-Care?
Why is there not
more competition on
(lower) costs?

Where can we find VALUE benchmarks?
29BA_2016_20160920_v1
Breast cancer
OUTCOMES
5-year survival rates
(stages 1-3 combined)
Healthcare Global (India) 86.9% (97% of US)
US average 89.2%
Cancer treatment
COSTS
Full set of intensity
modulated radiation
treatments
Healthcare Global (India) US$ 2,900 (13% of US)
US average US$ 22,000
* High-precision, robotic radiosurgery system (costing US$ 8 million)
Source: HCG, “Delivering World-Class Healthcare Affordably”/ HBR
Super-hub: 1
 Bangalore (is also serving
as a hub in the network)
 Center of Excellence for
the overall chain
 Most highly trained
oncologists & pathologists
 Unique equipment, e.g.
Cyberknife*
Regional hubs: 3+1
 Ahmedabad, Mumbai,
Chennai (and Bangalore)
 Sophisticated procedures and
surgery (patient channeling)
 Oncology specialists (also
leveraging telemedicine)
 High-end equipment, e.g.
PET-CT scanners, cyclotrons
Spokes: 17
 Gateways around the four
hubs (first patient contact)
 Diagnosis, routine treatment
and follow-up care
 Oncologists (access to
databases/ algorithms/ tools)
 Standard equipment and two-
way audio/video capability

Which factors drive healthcare DISRUPTION?
30BA_2016_20160920_v1
Managing Healthcare
Financing Healthcare
Competing in Healthcare
 Managing consistently against costs and quality criteria
 Specialization within healthcare delivery, e.g. dialysis chains
 Superior brand appealing to the “informed” patient
 Outcome based payments, also considering quality
 Voluntary “out-of-pocket” consumer spending
 Privatizations given growing public deficits
 Globalization of healthcare, e.g. patients, professionals, providers
 Healthcare product companies forward integrating into healthcare
 Novel virtual value chains exploiting knowledge and data better
Source: 2nd Global Medtech Industry Report 2014

Which companies are shaping the disruption?
31BA_2016_20160920_v1
Fully integrated
Disease Management
Strategy
Fully integrated
Disease Management
Offerings
Fully integrated
Disease Management
Processes & IT landscape
EUropean Clinical DB
for Dialysis (KPIs!)
§ Original database
created in 1998
§ Benchmarking in
Germany since 2002
§ Covering all EU
dialysis since 2014
(100,000+ patients)
Source: Fresenius home page and reports
EuCliD
Database
1998
Care
Coordination
2013
Predictive
Analytics
2015
Care Coordination (with
revenue target)
§ Bundled non-dialysis
services since 2013
§ Based on internal
COM-Ex & OP-EX
§ From individual
services to holistic and
coordinated care
Renal Research Institute (scientific
arm)
§ “Big Data” modeling for renal care
since 2015
§ Outcomes monitoring and
predictions for high risk patients
§ Lower costs from major reductions
in hospital admissions and stays

Who are the future LEADERS in healthcare?
32BA_2016_20160920_v1
Integrated healthcare products/ services
International providers
Telemedicine players
ICT/ data players
Healthcare product companies
Specialized healthcare players
Selected examplesType of players

Where will the future healthcare leaders come
from?
33BA_2016_20160920_v1

BA_2016_20160920_v1 34
Beyond reimbursement – Panel discussion

BSLW WLAN
35BA_2016_20160920_v1

You can participate today in two different ways
36BA_2016_20160920_v1
1. Open a browser on your smart device
2. Go to the website www.slido.com
3. Type-in the event code #3322
Post new questions/
endorse posted ones
(to ask the panel)
Answer a poll and
see the real-time
results on the screen

Now, it is your turn to get involved and ask
questions!
37BA_2016_20160920_v1
Please
 Introduce yourself with name/affiliation
 Make your contributions
 Target a question to panel member(s)
Herb Riband Zayna Khayat Ben van Ommen

Your hosts stand for ….
38BA_2016_20160920_v1
Visionary thinking on
holistic Business Model
Innovation for Healthcare &
Life Science Stakeholders

ConCeplus GmbH ist eine im Luzerner Handelsregister
eingetragene Unternehmensberatung.
Handelsregister Nr: CHE-459.633.547
Diese Publikation kann sich zum Teil auf Daten Dritte stützen,
die dann nach besten Wissen und Gewissen verwendet
wurden. Für allfällige Irrtümer ab Datenquelle übernimmt
ConCep+ keine Haftung.
Alle Inhalte, Ideen, Konzepte und Bilder sind urheberrechtlich
geschützt. Das Erstellen von Kopien im Ganzen oder in Teilen
ist untersagt; Ausnahme bilden lediglich mandatsbezogene
Dokumentationen.
Anschrift:
ConCeplus GmbH
Lützelaustrasse 44
CH-6353 Weggis
+41 79 254 0968
info@conceplus.com
www.conceplus.com
© ConCep+ 2015

Basel Agenda 2016 during the Life Science Week 2016

Empfohlen

Empfohlen

Weitere ähnliche Inhalte

Andere mochten auch

Andere mochten auch (20)

Ähnlich wie Basel Agenda 2016 during the Life Science Week 2016

Ähnlich wie Basel Agenda 2016 during the Life Science Week 2016 (20)

Kürzlich hochgeladen

Kürzlich hochgeladen (20)

Basel Agenda 2016 during the Life Science Week 2016